| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $386M | $364M | $439M | 5.9% | -12.1% |
| Op. Income | $31M | -$10M | -$126M | 410.8% | 124.5% |
| Gross Margin | 68.8% | 67.8% | 70.0% | 1.1pp | -1.1pp |
| Net Margin | 5.5% | 29.5% | -26.9% | -24.0pp | 32.4pp |
| EPS (Diluted) | $0.43 | $2.14 | $-2.38 | -79.9% | 118.1% |
| Free Cash Flow | $36M | -$13M | $43M | 371.1% | -17.0% |
| Item | Amount |
|---|---|
| REVENUE | $386M |
| Cost of Revenue | $120M |
| GROSS PROFIT | $266M |
| R&D Expenses | $0 |
| Selling & Marketing | $128M |
| General & Administrative | $107M |
| SG&A Expenses | $235M |
| Other Expenses | $0 |
| Operating Expenses | $235M |
| Cost & Expenses | $355M |
| OPERATING INCOME | $31M |
| Interest Income | $0 |
| Interest Expense | $3M |
| Other Income/Expenses | -$3M |
| INCOME BEFORE TAX | $27M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $21M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $21M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $21M |
| D&A | $13M |
| EBIT | $30M |
| EBITDA | $43M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $386M |
| Cost of Revenue | $120M |
| GROSS PROFIT | $266M |
| R&D Expenses | $0 |
| Selling & Marketing | $128M |
| General & Administrative | $107M |
| SG&A Expenses | $235M |
| Other Expenses | $0 |
| Operating Expenses | $235M |
| Cost & Expenses | $355M |
| OPERATING INCOME | $31M |
| Interest Income | $0 |
| Interest Expense | $3M |
| Other Income/Expenses | -$3M |
| INCOME BEFORE TAX | $27M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $21M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $21M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $21M |
| D&A | $13M |
| EBIT | $30M |
| EBITDA | $43M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $21M |
| Depreciation & Amortization | $13M |
| Stock-Based Compensation | $6M |
| Deferred Income Tax | -$7M |
| Other Non-Cash Items | $11M |
| Change in Working Capital | -$7M |
| OPERATING CASH FLOW | $36M |
| Capital Expenditure | -$18.0K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $9M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $9M |
| Net Debt Issuance | $10M |
| Common Stock Repurchased | $20.0K |
| Common Dividends Paid | -$3M |
| Other Financing Activities | $3M |
| NET CASH FROM FINANCING | $9M |
| FREE CASH FLOW | $36M |
| Net Change in Cash | $60M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $264M |
| Short-Term Investments | $1M |
| Net Receivables | $60M |
| Inventory | $180M |
| Other Current Assets | $67M |
| TOTAL CURRENT ASSETS | $572M |
| PP&E (Net) | $452M |
| Goodwill | $84M |
| Intangible Assets | $46M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $291M |
| TOTAL NON-CURRENT ASSETS | $872M |
| TOTAL ASSETS | $1.4B |
| Account Payables | $29M |
| Short-Term Debt | $35M |
| Deferred Revenue | $7M |
| Other Current Liabilities | $20M |
| TOTAL CURRENT LIABILITIES | $284M |
| Long-Term Debt | $214M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $96M |
| TOTAL NON-CURRENT LIABILITIES | $372M |
| TOTAL LIABILITIES | $656M |
| Common Stock | $91.0K |
| Additional Paid-In Capital | $628M |
| Retained Earnings | $1.8B |
| Treasury Stock | -$1.6B |
| Accum. Other Comp. Income | -$114M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $788M |
| Minority Interest | $0 |
| TOTAL EQUITY | $788M |
| TOTAL LIABILITIES & EQUITY | $1.4B |
| Total Debt | $311M |
| Net Debt | $47M |
